EIDELMAN VIRANT CAPITAL Evogene Ltd. Transaction History

EIDELMAN VIRANT CAPITAL portfolio value:

$96,000
portfolio value

EIDELMAN VIRANT CAPITAL quarter portfolio value change:

+7.79%
quarter

Evogene Ltd. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -5K $0.83 117K
Q2 2022 share 0.00% 0 shares -51K $0.77 117K
Q1 2022 share Increase +3.54% 4K shares -33K $1.3 117K
Q4 2021 share Increase 0.00% 113K shares 185K $1.66 113K
Q1 2021 share Decrease -100.00% -15.1K shares -71K $5.04 0
Q4 2020 share Decrease -71.83% -38.5K shares -148K $4.7 15.1K
Q3 2020 share Decrease -17.03% -11K shares 154K $3.96 53.6K
Q2 2020 share Increase 0.00% 64.6K shares 65K $1 64.6K
Q3 2019 share Decrease -100.00% -63.6K shares -102K $1.58 0
Q2 2019 share Increase 0.00% 63.6K shares 102K $1.61 63.6K
Q3 2017 share Decrease -100.00% -32.3K shares -163K $4.44 0
Q2 2017 share 0.00% 0 shares -9K $5.06 32.3K
Q1 2017 share Decrease -32.29% -15.4K shares -71K $5.35 32.3K
Q4 2016 share Increase +147.15% 28.4K shares 120K $5.1 47.7K
Q3 2016 share Decrease -10.65% -2.3K shares -12K $6.38 19.3K
Q2 2016 share Increase +2.37% 500 shares -3.20K $6.24 21.6K
Q1 2016 share Increase +21.97% 3.8K shares -795 $6.51 21.1K